| Literature DB >> 26522962 |
Qing-Bo Lv1, Xin Fu2, Hai-Ming Jin1, Hai-Chao Xu1, Zhe-Yu Huang1, Hua-Zi Xu1, Yong-Long Chi1, Ai-Min Wu1.
Abstract
The relationship between weight change and risk of hip fracture is still controversial. We searched PubMed and Embase for studies on weight change and risk of hip fracture. Eight prospective studies were included. The weight loss studies included 85592 participants with 1374 hip fractures, and the weight gain studies included 80768 participants with 732 hip fractures. Weight loss is more likely a risk factor of hip fracture, with an adjusted RR (Relative Risk) (95% CI) of 1.84 (1.45, 2.33). In contrast, weight gain can decrease the risk of hip fracture, with an adjusted RR (95% CI) of 0.73 (0.61, 0.89). Dose-response meta-analysis shows that the risk of hip fracture is an ascending curve, with an increase of weight loss above the line of RR = 1; this trend is consistent with the results of forest plots that examine weight loss and hip fracture. For weight gain and risk of hip fracture, the descending curve below the line of RR = 1; this trend is consistent with the results of forest plots that examine weight gain and hip fracture. Our meta-analysis suggests that weight loss may be a risk factor for hip fracture and that weight gain may be a protective factor for hip fracture.Entities:
Mesh:
Year: 2015 PMID: 26522962 PMCID: PMC4629201 DOI: 10.1038/srep16030
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The selection of literature for included studies.
Characteristics of Prospective Studies on Weight Loss and Hip Fracture.
| Source | No. of participants | Location/Period | Gender | Age (years) | No. of cases | Measure/Range of Loss | Study Quality | Adjustment for Covariates |
|---|---|---|---|---|---|---|---|---|
| Langlois | 2413 | United States 1985–1992 | M | 67–104 | 72 HF | Weight Loss: Q1≤5% 5% < Q2 < 10% Q3≥10% | 7 | BMI at age 50 year, age, number of medical conditions, low mental status score, physical disability. |
| Langlois | 2180 | United States 1982–1992 | F | 50–74 | 171 HF | Weight Loss: Q1≤5% 5% < Q2 < 10% Q3≥10% | 8 | BMI, age at baseline; cigarette smoking (current, former, never); history of chronic diseases based on self-reported doctors’ diagnoses of bronchitis, thyroid disease, diabetes, kidney disease, heart disease or stroke; and alcohol consumption (none or any consumed in the past year). |
| Meyer | 39089 | Norway 1974–1978 | F:19938 M:19151 | 37–58 | 207HF | Weight Loss (kg/12 years): F:Q1:Loss of 1.3 to gain of 1.5 Q2:Loss of >1.3 M:Q1:Loss of 0.9 to gain of 2.0 Q2:Loss of >0.9 | 9 | Age at screening, weight variability (root mean square error), mean body mass index, body height, self-reported physical activity at work and during leisure, diabetes mellitus, disability pension, marital status and smoking habits. |
| Amador | 1749 | United States 1993–2001 | F: 1008 M: 741 | ≥65 | 18HF | Weight Loss: Q1≤10% Q2 > 10% | 7 | Sociodemographic variables included age and gender, smoking status, medical conditions, depressed symptomatology, BMI, waist circumference, grip strength. |
| Langlois | 3683 | United States 1983–1992 | F | 67–104 | 253HF | Weight Loss: Q1≤5% 5% < Q2 < 10% Q3≥10% | 8 | Age at baseline, body mass index at age 50 years, cigarette smoking, alcoholconsumption in the past year, number of medical conditions, impaired mobility, and use of thiazide diuretics. |
| Ensrud | 6785 | United States 1986–2001 | F | ≥65 | 400HF | Weight Loss: Q1<5% Q2≥5% | 8 | Age, health status, smoking, physical activity, medical conditions, history of fracture, BMI, neuromuscular function, and hipbone density. |
| Mussolino | 2879 | United States 1982–1992 | M | 45–74 | 71HF | Weight Loss: Q1≤5% 5%<Q2<10% Q3≥10% | 8 | Self-reported data on age at baseline, previous fractures other than hip (none, any), smoking status (current, not current), alcohol consumption in the past year (none, any), nonrecreational physical activity (much, moderate, little or no exercise), chronic disease prevalence, calcium intake (mg/day), calories (kcal/day), protein consumption (g/day), and weight loss from maximum. |
| French | 33834 | United States 1986–1992 | F | 55–69 | 182HF | Weight loss: Q1≤10% Q2>10% | 7 | Baseline values of age, waist/hip ratio, BMI, BMI2, smoking status (never, former, current), pack years of cigarettes, education (<high school, high school, >high school), physical activity (low, medium, high), alcohol (0, <4, ≥4 g/d), marital status (yes/no), hormone replacement (never, former, current). |
aHF: Hip fracture.
bStudy quality was judged based on the Newcastle-Ottawa Scale (range, 1–9 stars).
cBMI: body mass index; BMD: Bone mineral density.
Characteristics of Prospective Studies on Weight Gain and Hip Fracture.
| Source | No. of participants | Location/Period | Gender | Age (years) | No. of cases | Measure/Range of Loss | Study Quality | Adjustment for Covariates |
|---|---|---|---|---|---|---|---|---|
| Langlois | 2413 | United States 1985–1986 | M | 67–104 | 72 HF | Weight Gain: Q1≤5% 5%<Q2<10% Q3≥10% | 7 | BMI at age 50 year, number of medical conditions, low mental status score, physical disability. |
| Meyer | 39089 | Norway 1974–1978 | F:19938 M:19151 | 37–58 | 207HF | Weight Gain(kg/12 years): F:Q1: Loss of 1.3 to gain of 1.5 Q2: Gain of 1.6 to 4.6 Q3:Gain of ≥ 4.7 M:Q1: Loss of 0.9 to gain of 2.0 Q2: Gain of 2.1 to 5.2 Q3:Gain of ≥5.3 | 9 | Age at screening, weight variability (root mean square error), mean body mass index, body height, self-reported physical activity at work and during leisure, diabetes mellitus, disability pension, marital status and smoking habits. |
| Amador | 1749 | United States 1993–2001 | F: 1008 M: 741 | ≥65 | 18HF | Weight Gain: Q1≤10% Q2>10% | 7 | Sociodemographic variables included age and gender, smoking status, medical conditions, depressed symptomatology, BMI, waist circumference, grip strength. |
| French | 33834 | United States 1986–1992 | F | 55–69 | 182HF | Weight Gain: Q1<10% Q2>10% | 7 | Baseline values of age, waist/hip ratio, BMI, BMI2, smoking status (never, former, current), pack years of cigarettes, education (<high school, high school, >high school), physical activity (low, medium, high), alcohol (0, <4, ≥4 g/d), marital status (yes/no), hormone replacement (never, former, current). |
| Langlois | 3683 | United States 1983–1992 | F | 67–104 | 253HF | Weight Gain: Q1≤5% 5%<Q2<10% Q3≥10% | 8 | Age at baseline, body mass index at age 50 years, cigarette smoking, alcohol consumption in the past year, number of medical conditions, impaired mobility, and use of thiazide diuretics. |
aHF: Hip fracture.
bStudy quality was judged based on the Newcastle-Ottawa Scale (range, 1–9 stars).
cBMI: body mass index; BMD: bone mineral density.
Assessment of quality of included studies on the use of Nine-Star Newcastle-Ottawa Scale.
| Selection | Outcome assessment | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Study (authors, year) | Representativeness of the exposed cohort | Selection of the nonexposed cohort | Ascertainment of exposure | Incident disease | Comparability | Assessment of outcome | Length of follow up | Adequacy of follow up | Score |
| Langlois | * | * | * | * | * | — | * | * | ******* |
| Langlois | * | * | — | * | ** | * | * | * | ******** |
| Meyer | * | * | * | * | ** | * | * | * | ********* |
| Amador | * | * | — | * | ** | * | — | * | ******* |
| Langlois | * | * | — | * | ** | * | * | * | ******** |
| Ensrud | * | * | * | * | * | * | * | * | ******** |
| Mussolino | * | * | — | * | ** | * | * | * | ******** |
| French | * | * | — | * | ** | — | * | * | ******* |
Note One asterisk means one score, studies with more scores on behalf of higher quality.
Figure 2Adjusted Relative Risks of hip fracture for the highest vs. reference category of weight loss.
Figure 3Adjusted Relative Risks of hip fracture for the highest vs. reference category of weight gain.
Figure 4Dose-response relationship between weight gain (A) and weight loss (B) and relative risk of hip fracture.
The solid line represents adjusted relative risk, and dotted lines represent the 95% confidence intervals for the fitted trend. The adjusted RR of weight gain is a descending curve below the line of RR = 1, whereas the adjusted RR of weight loss is an ascending curve above the line of RR = 1. The line trend of dose-response meta-analysis is consistent with the results of the forest plots in Figs 2 and 3.